AMY DILLON: Open Payments
NPI 1386614089 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 29 payments from 8 companies in 2025. Trend: 2023 $613 · 2024 $713 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $139 |
| PFIZER INC. | 7 | $137 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $118 |
| SK Life Science, Inc. | 2 | $67 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Smith+Nephew, Inc. | 1 | $19 |
Products named: ELIQUIS, XIFAXAN, ZERBAXA, DALVANCE, UBRELVY, LEQVIO, JARDIANCE, AVYCAZ.
Industry payments across NC — which companies pay providers there.
